This IDC Health Insights report is the second of a three-part life science R&D IDC MarketScape series focused on IT outsourcing (ITO). With a specific focus on life science R&D ITO, this report seeks to compare major IT service providers with each other, based on operational, business, and market-centric criteria that should be important to life science companies when considering the selection of an external service provider to take over noncore IT activities.
Alan Louie, research director of IDC Health Insights' Life Science R&D Technology and Strategy research, noted, "ITO in the life sciences is more important than ever as leading life science companies increasingly rely on IT service provider partners to help them continue to grow and transform while concurrently delivering ongoing operational excellence. In combination with BPO and strategic consulting efforts, IT outsourcing is a critical component of life science corporate strategies. The selection of optimal partners to execute on these increasingly externalized business strategies contributes significantly to a company's potential for success. IDC expects that over the near term, IT outsourcing will continue to grow at double-digit rates as the industry continues to grow and expand."